New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareEloralintide vs Matrixyl

Eloralintide vs Matrixyl

Side-by-side comparison of key properties, dosing, and research.

GLP-1 / Weight Loss Agonists
Eloralintide
Skin & Cosmetic
Matrixyl
Summary
Eloralintide is a long-acting amylin analog under development by OPKO Health. Amylin is co-secreted with insulin and regulates post-meal glucose by slowing gastric emptying, suppressing glucagon, and promoting satiety. Eloralintide is designed for once-weekly dosing, differentiating it from the short-acting pramlintide (Symlin). It is being studied for obesity and type 2 diabetes as a complement to GLP-1 based therapies.
Matrixyl is the most widely used collagen-stimulating cosmetic peptide. As a matrikine — a fragment of type I procollagen — it signals skin cells to synthesize new collagen, elastin, and fibronectin, reducing wrinkle depth and improving skin firmness and elasticity.
Half-Life
~7 days (estimated, long-acting design)
N/A — topical; sustained signaling effects on fibroblasts persist beyond single application
Admin Route
SubQ
Topical
Research
Typical Dose
Under investigation in Phase 1/2 trials
3–8% concentration
Frequency
Once weekly
Once or twice daily
Key Benefits
  • Once-weekly dosing (vs multiple daily injections for pramlintide)
  • Appetite suppression via central amylin receptor activation
  • Reduction in post-meal glucagon secretion
  • Complementary mechanism to GLP-1 agonists for combination therapy
  • Slows gastric emptying for prolonged satiety
  • Potential additive weight loss when combined with GLP-1 agents
  • Stimulates collagen I, III, and IV synthesis
  • Increases fibronectin and glycosaminoglycan production
  • Reduces wrinkle depth and length by 27–68% (studies)
  • Improves skin firmness and elasticity
  • Reduces dark circles and undereye bags
  • Synergistic with retinol, vitamin C, and growth factors
  • Suitable for all skin types including sensitive
  • Well-studied with published clinical data
Side Effects
  • Nausea
  • Vomiting
  • Decreased appetite
  • Injection site reactions
  • +1 more
  • Exceptional safety profile
  • Non-irritating, suitable for sensitive skin
  • No known adverse effects at cosmetic concentrations
Stacks With